Portal de investigación
Post-transplant cyclophosphamide separates graft-versus host disease (GVHD) and graft versus leukemia (gvl) effects after HLA- matched stem-cell transplantation (sct) for AML
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Shimoni, A.
- Peczynski, C.
- Labopin, M.
- Kulagin, A.
- Meijer, E.
- Cornelissen, J.
- Ciceri, F.
- Choi, G.
- Rovira, M.
- van Gorkom, G.
- Kroger, N.
- Koc, Y.
- Vydra, J.
- Diez-Martin, J.
- Solano, C.
- Chiusolo, P.
- Nagler, A.
- Mohty, M.
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Cita
Shimoni,A,Peczynski,C,Labopin,M,Kulagin,A,Meijer,E,Cornelissen,J,Ciceri,F et al. Post-transplant cyclophosphamide separates graft-versus host disease (GVHD) and graft versus leukemia (gvl) effects after HLA- matched stem-cell transplantation (sct) for AML. 48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT). 2022. CZECH REPUBLIC-MAR 19-23. CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND:SPRINGERNATURE. 2022 p.p. 104-104.